Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

Multivitamins Won't Boost Standard HIV Care, Study Finds

October 18, 2012

According to a report published in the October 17 issue of the Journal of the American Medical Association, taking high doses of multivitamin supplements did not lessen the risk of HIV disease progression or fatalities for Tanzanian patients receiving standard medications for suppressing the virus. The daily supplements appeared to be linked to potentially harmful increased levels of a particular liver enzyme. Over the past 15 years, the combination of medications known as highly active antiretroviral therapy, or HAART, has greatly decreased HIV-related disease and fatalities. Previous studies have also shown that high doses of multivitamins may reduce HIV-related illness and death in those not receiving HAART, but the safety and effectiveness of combining the two regimens had not been examined.

In this newly published study, researchers compared effects of high-dose multivitamin supplementation and standard-dose supplementation in Tanzanian HIV patients receiving HAART. The patients received daily doses that contained either high or standard levels of vitamin B complex, vitamin C, and vitamin E. However, the study was halted after a median follow-up of 15 months when evidence was found that the patients receiving high doses of supplements had unhealthily increased levels of the liver enzyme alanine transaminase. According to the researchers, led by Sheila Isanaka of the Harvard School of Public Health, at that point there was no difference in disease progression or death risk between those patients receiving standard or high doses of the multivitamin supplementation.

[Editor's Note JAMA. 2012; 308(15):1535-1544. Doi:10.1001/jama.2012.13083. "Effect of High-Dose vs. Standard-Dose Multivitamin Supplementation at the Initiation of HAART on HIV Disease Progression and Mortality in Tanzania: A Randomized Controlled Trial," Isanaka, S., Mugusi, F., Hawkins, C., Spiegelman, D., Okuma, J., Aboud S., Guerino, C., and Fawzi, W.W.]

Back to other news for October 2012

Adapted from:
US News & World Report
10.16.2012; HealthDay


  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
It's Time to Tell Our Patients to Stop Their Vitamin Supplements
An Introduction to Dietary Supplements for People Living With HIV/AIDS
Ask a Question About Diet or Nutrition at TheBody.com's "Ask the Experts" Forums
More on Multivitamins and HIV/AIDS

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement